# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-116466
Filing Date
2022-11-09
Accepted
2022-11-09 16:07:07
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | cldx-20220930x10q.htm iXBRL | 10-Q | 1401348
2 | EXHIBIT-3.1 | cldx-20220930xex3d1.htm | EX-3.1 | 158571
3 | EXHIBIT-10.1 | cldx-20220930xex10d1.htm | EX-10.1 | 288071
4 | EXHIBIT-10.2 | cldx-20220930xex10d2.htm | EX-10.2 | 42033
5 | EXHIBIT 31.1 | cldx-20220930xex31d1.htm | EX-31.1 | 15024
6 | EXHIBIT 31.2 | cldx-20220930xex31d2.htm | EX-31.2 | 15004
7 | EXHIBIT 32.1 | cldx-20220930xex32d1.htm | EX-32.1 | 9465
| Complete submission text file | 0001104659-22-116466.txt |  | 6765086

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | cldx-20220930.xsd | EX-101.SCH | 31485
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | cldx-20220930_cal.xml | EX-101.CAL | 45651
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cldx-20220930_def.xml | EX-101.DEF | 142033
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cldx-20220930_lab.xml | EX-101.LAB | 335825
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cldx-20220930_pre.xml | EX-101.PRE | 245543
58 | EXTRACTED XBRL INSTANCE DOCUMENT | cldx-20220930x10q_htm.xml | XML | 1354455

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 221372563
SIC: 2835 In Vitro & In Vivo Diagnostic Substances